Learn why this royalty company believes it is the best way to play commodities and inflation. on 06/22/2021. Learn More

Streetwise Reports' Article Archives — June 2019 back to current month (21)

Biotech's Data Well Received at Neurodegenerative Diseases Symposium (06/28/2019)

The company shared findings from its lead clinical program, in Alzheimer's disease.


Biopharma Responds to FDA Inquiry Concerning Non-Opioid Pain Reliever (06/28/2019)

The firm believes adequate therapeutic safety and efficacy data exist to support regulatory approval.


Dova Pharmaceuticals Shares Increase 35% Overnight with FDA Approval (06/27/2019)

The pharmaceutical stock enjoyed a large boost, thanks largely to FDA approval of its supplemental new drug application for DOPTELET for treatment of chronic immune thrombocytopenia.


Strategic Partnership Highlights Global Ambitions for NASH Therapy (06/26/2019)

The deal terms and the partner's attractive attributes are discussed in an H.C. Wainwright & Co. report.


Coverage Initiated on 'Solid Platform Company' with Sanofi Partnership (06/26/2019)

The reasons why this biopharma makes a compelling investment are outlined in a ROTH Capital Partners report.


Cannabis Company Has Successful Maiden Run Using Extraction Technology (06/22/2019)

The procedure resulted in two types of cannabinoids: water soluble and oil based.


Biotech in Neuro Diseases Adds Parkinson's Expert to Scientific Advisory Board (06/22/2019)

The expert brings to the board a deep knowledge of neurodegeneration.


Biotech Reports 'Eye-Catching, Topline Results' from RSV Vaccine Study (06/19/2019)

The data and how the asset stacks up to others were covered in a ROTH Capital Partners report.


Precision Medicine Firm Announces 'Positive' Data in Lymphoma Study (06/19/2019)

The highlights of the results were presented in an H.C. Wainwright & Co. report.


Biopharma Advances Dose Escalation Trial in Alcoholic Hepatitis (06/19/2019)

The company received approval to proceed with the next and final dose level.


Cannabis Producer Achieves Commercial Sale Milestone (06/19/2019)

The transaction marks the start of a revenue stream for the company.


Developer of Animal Nutrition Supplements to Form JV for Online Product Sales (06/15/2019)

The new partner has expertise in online marketing and e-commerce.


Biotech Receives FDA Approval of Second-Generation Medical Device (06/12/2019)

The product's improvements and the company's commercialization approach were summarized in a Ladenburg Thalmann report.


Interim Results Put Biopharma with Tenbagger Potential 'Back on the Map' (06/11/2019)

A key upcoming catalyst and the impact of recent positive trial results are addressed in a ROTH Capital Partners report.


Healthcare Tech Firm Expands Medical Client Base in Texas (06/11/2019)

These new customers' patient accounts are already being imported into the company's platform.


Biotech to Present Alzheimer's Disease Therapeutic at Keystone Symposium (06/08/2019)

The focus will be the Canadian company's lead monoclonal antibody candidate.


Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic (06/05/2019)

An explanation of the categorization and its implications are provided in a Paradigm Capital report.


Bacteria Test Developer Reiterates Revenue Should Double in 2019 (06/05/2019)

The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report.


Coverage Initiated on Biotech Whose Therapies 'Can Compete with CAR-Ts' (06/05/2019)

The reasons for the Buy rating on the U.K. firm are delineated in a ROTH Capital Partners report.


Canadian Cannabis Firm Featured in Investorideas.com 'Potcast' (06/05/2019)

The company's recent deal, progress on its cannabis beverages and its product ideas for the future were discussed.


Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses (06/03/2019)

The offering should facilitate a more individualized treatment plan for patients.


More Archives

2021May Apr Mar Feb Jan

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes

"Momentum continues to build for VIV."
– Joseph Gomes, Wm Smith & Co.